DOCS Stock Analysis: Buy, Sell, or Hold?
DOCS - Doximity, Inc.
$22.29
0.52 (2.39%)
▲
5d:
-2.49%
30d:
+10.13%
90d:
+5.89%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Smart Money Distribution
None View Scanner →
Strength: 6.1/10
Get Alerted When DOCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DOCS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.78
Based on 4.4% avg growth
INTRINSIC VALUE TODAY
$22.84
2.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOCS is currently trading at $22.29, which is considered extended relative to its 30-day fair value range of $20.13 to $21.80. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.8) compared to its historical average (18.3). Remarkably, the market is currently pricing in an annual earnings decline of 9.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $20.16, while resistance sits at $23.57.
Market Sentiment: DOCS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DOCS is in a strong uptrend. Immediate support is located at $20.16, while resistance sits at $23.57.
Market Sentiment: DOCS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.13 -
$21.80
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding DOCS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($24.53)
Trading Range Analysis
30-Day Trading Range
$20.13 -
$21.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.16
Resistance Level
$23.57
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.75
Wall Street Target
$24.53
(+10.0%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
-69.0%
Profit Margin
30.4%
Valuation Discount vs History
-9.1% cheaper
PE vs Historical
13.8 vs 18.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.1%
(market-implied from PE analysis)
1-Year Target
$20.26
(-9%)
2-Year Target
$18.42
(-17%)
3-Year Target
$16.74
(-25%)
3-Yr Target (if PE normalizes)
(PE: 14→18)
$22.28
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 4.8%)
$40.62
(+82%)
Base:
(SPY PE: 13.8, Growth: 4.8%)
$25.65
(+15%)
Bear:
(PE: 11.7, Growth: 4.8%)
$21.80
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 22.21 | Current EPS (TTM): $0.98
Bull Case
$39.60
(+78%)
Analyst growth 65.4%, PE expands to 24.4
Base Case
$36.00
(+62%)
Market implied 65.4%, PE stable at 22.2
Bear Case
$14.80
(-34%)
Severe decline -20.0%, PE contracts to 18.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.8 to 18.3
Stabilization Target:
$29.66
(+33.1%)
PE Expansion Potential:
+33.1%
Share & Embed Analysis
Last updated: July 13, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Siddharth Sitaram
SELL
2427 shares
2026-04-10
Siddharth Sitaram
SELL
2319 shares
2026-03-10
Kira Scherer Wampler
SELL
2000 shares
2026-03-03
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 63 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 61 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 61 BUY |
Advanced DOCS Option Strategies
Professional options setups generated by AI based on today's DOCS price and gamma walls.
